Product Program year 2025 Source: CMS Open Payments

Confirm RX

Device Cardiac Rhythm Management

PDI 05415067027320

Open in the dashboard

General payments

$1,040,318

22,491 payments

Research payments

$2,312,517

294 payments

Through program year 2025, $1,040,318 in general payments and $2,312,517 in research payments were reported against Confirm RX (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

9 rows
Year Kind Amount Payments
2025 Research $329,089 11
2024 General $68,477 667
2024 Research $142,768 20
2023 General $77,053 1,941
2023 Research $789,460 45
2022 General $369,875 8,683
2022 Research $108,548 97
2021 General $524,913 11,200
2021 Research $942,652 121

Breakdown

Who paid General payments · program years 2021–2024
  1. Abbott Laboratories $1,040,318 22,491 payments
Top recipients General payments · program year 2024
  1. Michael Katcher Cardiovascular Disease · Salem, MA $23,625 35% · 1 payment
  2. Dhanunjaya Lakkireddy Clinical Cardiac Electrophysiology · Kansas City, KS $12,551 18% · 12 payments
  3. Praneeth Katrapati Clinical Cardiac Electrophysiology · Phoenix, AZ $6,000 9% · 1 payment
  4. Upmc Hamot Teaching hospital · PA $5,000 7% · 1 payment
  5. Arindam Banerjee Interventional Cardiology · Conroe, TX $692 1% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Cardiovascular Disease Internal Medicine $29,155 46% · 107 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $22,183 35% · 72 practitioners
  3. Interventional Cardiology Internal Medicine $4,913 8% · 68 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $2,876 5% · 36 practitioners
  5. Internal Medicine $997 2% · 12 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Massachusetts $23,625 35% · 1 recipient
  2. Kansas $12,551 18% · 1 recipient
  3. Texas $9,068 13% · 108 recipients
  4. Arizona $7,390 11% · 24 recipients
  5. Pennsylvania $5,095 7% · 4 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

22,491 general · 294 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record